Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

CLPP deficiency protects against metabolic syndrome but hinders adaptive thermogenesis.

Becker C, Kukat A, Szczepanowska K, Hermans S, Senft K, Brandscheid CP, Maiti P, Trifunovic A.

EMBO Rep. 2018 Mar 27. pii: e45126. doi: 10.15252/embr.201745126. [Epub ahead of print]

PMID:
29588285
2.

Optimal extraction methods for the simultaneous analysis of DNA from diverse organisms and sample types.

Hermans SM, Buckley HL, Lear G.

Mol Ecol Resour. 2018 Feb 2. doi: 10.1111/1755-0998.12762. [Epub ahead of print]

PMID:
29394525
3.

DARS2 protects against neuroinflammation and apoptotic neuronal loss, but is dispensable for myelin producing cells.

Aradjanski M, Dogan SA, Lotter S, Wang S, Hermans S, Wibom R, Rugarli E, Trifunovic A.

Hum Mol Genet. 2017 Nov 1;26(21):4181-4189. doi: 10.1093/hmg/ddx307.

PMID:
28985337
4.

Text messaging to decrease tuberculosis treatment attrition in TB-HIV coinfection in Uganda.

Hermans SM, Elbireer S, Tibakabikoba H, Hoefman BJ, Manabe YC.

Patient Prefer Adherence. 2017 Aug 31;11:1479-1487. doi: 10.2147/PPA.S135540. eCollection 2017.

5.

Skin-to-skin back transfers provide a feasible, safe and low-stress alternative to conventional neonatal transport.

Hennequin Y, Grevesse L, Gylbert D, Albertyn V, Hermans S, Van Overmeire B.

Acta Paediatr. 2018 Jan;107(1):163-164. doi: 10.1111/apa.14071. Epub 2017 Oct 2. No abstract available.

PMID:
28898475
6.

The impact of the roll-out of rapid molecular diagnostic testing for tuberculosis on empirical treatment in Cape Town, South Africa.

Hermans S, Caldwell J, Kaplan R, Cobelens F, Wood R.

Bull World Health Organ. 2017 Aug 1;95(8):554-563. doi: 10.2471/BLT.16.185314. Epub 2017 Apr 28.

7.

Treatment decisions and mortality in HIV-positive presumptive smear-negative TB in the Xpert™ MTB/RIF era: a cohort study.

Hermans SM, Babirye JA, Mbabazi O, Kakooza F, Colebunders R, Castelnuovo B, Sekaggya-Wiltshire C, Parkes-Ratanshi R, Manabe YC.

BMC Infect Dis. 2017 Jun 16;17(1):433. doi: 10.1186/s12879-017-2534-2.

8.

Versatile Two-Step Functionalization of Nanocarbons: Grafting of Propargylic Groups and Click Post-Functionalization.

Desmecht A, Hermans S, Riant O.

ChemistryOpen. 2017 Feb 28;6(2):231-235. doi: 10.1002/open.201600170. eCollection 2017 Apr.

9.

Low incidence of the immune reconstitution inflammatory syndrome among HIV-infected patients starting antiretroviral therapy in Gabon: a prospective cohort study.

Janssen S, Osbak K, Holman R, Hermans S, Moekotte A, Knap M, Rossatanga E, Massinga-Loembe M, Alabi A, Adegnika A, Meenken C, van Vugt M, Kremsner PG, Meintjes G, van der Poll T, Grobusch MP.

Infection. 2017 Oct;45(5):669-676. doi: 10.1007/s15010-017-1000-9. Epub 2017 Mar 27.

10.

Defect-free functionalized graphene sensor for formaldehyde detection.

Tang X, Mager N, Vanhorenbeke B, Hermans S, Raskin JP.

Nanotechnology. 2017 Feb 3;28(5):055501. doi: 10.1088/1361-6528/28/5/055501. Epub 2016 Dec 23.

PMID:
28008891
11.

Highlights from the ISCB Student Council Symposia in 2016.

Cuypers B, Jacobsen A, Siranosian B, Schwahn K, Conard AM, Aben N, Hassan M, Fatima N, Hermans SMA, Woghiren M, Meysman P, Rahman F, Jigisha A.

F1000Res. 2016 Dec 15;5. pii: ISCB Comm J-2852. doi: 10.12688/f1000research.10389.1. eCollection 2016.

12.

The mass miniature chest radiography programme in Cape Town, South Africa, 1948 - 1994: The impact of active tuberculosis case finding.

Hermans SM, Andrews JR, Bekker LG, Wood R.

S Afr Med J. 2016 Dec 1;106(12):1263-1269. doi: 10.7196/SAMJ.2016.v106.i12.10744.

PMID:
27917775
13.

pH controlled adsorption of water-soluble ruthenium clusters onto carbon nanotubes and nanofiber surfaces.

Mager N, Lamme WS, Carlier S, Hermans S.

Phys Chem Chem Phys. 2016 Nov 30;18(47):32210-32221.

PMID:
27849070
14.

Bacteria as Emerging Indicators of Soil Condition.

Hermans SM, Buckley HL, Case BS, Curran-Cournane F, Taylor M, Lear G.

Appl Environ Microbiol. 2016 Dec 15;83(1). pii: e02826-16. Print 2017 Jan 1.

15.

An integrated community TB-HIV adherence model provides an alternative to DOT for tuberculosis patients in Cape Town.

Kaplan R, Caldwell J, Hermans S, Adriaanse S, Mtwisha L, Bekker LG, Jennings K, Wood R.

Int J Tuberc Lung Dis. 2016 Sep;20(9):1185-91. doi: 10.5588/ijtld.15.0855.

PMID:
27510244
16.

Loss of CLPP alleviates mitochondrial cardiomyopathy without affecting the mammalian UPRmt.

Seiferling D, Szczepanowska K, Becker C, Senft K, Hermans S, Maiti P, König T, Kukat A, Trifunovic A.

EMBO Rep. 2016 Jul;17(7):953-64. doi: 10.15252/embr.201642077. Epub 2016 May 6.

17.

Sustainable Process for the Preparation of High-Performance Thin-Film Composite Membranes using Ionic Liquids as the Reaction Medium.

Mariën H, Bellings L, Hermans S, Vankelecom IF.

ChemSusChem. 2016 May 23;9(10):1101-11. doi: 10.1002/cssc.201600123. Epub 2016 Apr 26.

PMID:
27116588
18.

The timing of tuberculosis after isoniazid preventive therapy among gold miners in South Africa: a prospective cohort study.

Hermans SM, Grant AD, Chihota V, Lewis JJ, Vynnycky E, Churchyard GJ, Fielding KL.

BMC Med. 2016 Mar 23;14:45. doi: 10.1186/s12916-016-0589-3.

19.

Tuberculosis in Cape Town: An age-structured transmission model.

Blaser N, Zahnd C, Hermans S, Salazar-Vizcaya L, Estill J, Morrow C, Egger M, Keiser O, Wood R.

Epidemics. 2016 Mar;14:54-61. doi: 10.1016/j.epidem.2015.10.001. Epub 2015 Oct 20.

20.

Crystal structure of a Pd4 carbonyl tri-phenyl-phosphane cluster [Pd4(CO)5(PPh3)4]·2C4H8O, comparing solvates.

Robeyns K, Willocq C, Tinant B, Devillers M, Hermans S.

Acta Crystallogr E Crystallogr Commun. 2016 Jan 6;72(Pt 2):120-3. doi: 10.1107/S205698901502441X. eCollection 2016 Feb 1.

21.

TB as a cause of hospitalization and in-hospital mortality among people living with HIV worldwide: a systematic review and meta-analysis.

Ford N, Matteelli A, Shubber Z, Hermans S, Meintjes G, Grinsztejn B, Waldrop G, Kranzer K, Doherty M, Getahun H.

J Int AIDS Soc. 2016 Jan 12;19(1):20714. doi: 10.7448/IAS.19.1.20714. eCollection 2016. Review.

22.

Temporal trends in TB notification rates during ART scale-up in Cape Town: an ecological analysis.

Hermans S, Boulle A, Caldwell J, Pienaar D, Wood R.

J Int AIDS Soc. 2015 Sep 25;18:20240. doi: 10.7448/IAS.18.1.20240. eCollection 2015.

23.

A Century of Tuberculosis Epidemiology in the Northern and Southern Hemisphere: The Differential Impact of Control Interventions.

Hermans S, Horsburgh CR Jr, Wood R.

PLoS One. 2015 Aug 19;10(8):e0135179. doi: 10.1371/journal.pone.0135179. eCollection 2015.

24.

Heterometal nanoparticles from Ru-based molecular clusters covalently anchored onto functionalized carbon nanotubes and nanofibers.

Vidick D, Ke X, Devillers M, Poleunis C, Delcorte A, Moggi P, Van Tendeloo G, Hermans S.

Beilstein J Nanotechnol. 2015 Jun 10;6:1287-97. doi: 10.3762/bjnano.6.133. eCollection 2015.

25.

Population-level tuberculosis incidence in the ART era.

Hermans S, Manabe Y.

Lancet Infect Dis. 2015 Sep;15(9):997-998. doi: 10.1016/S1473-3099(15)00146-2. Epub 2015 Jun 22. No abstract available.

PMID:
26112076
26.

Impact of Anti-Retroviral Treatment and Cotrimoxazole Prophylaxis on Helminth Infections in HIV-Infected Patients in Lambaréné, Gabon.

Janssen S, Hermans S, Knap M, Moekotte A, Rossatanga EG, Adegnika AA, Bélard S, Hänscheid T, Grobusch MP.

PLoS Negl Trop Dis. 2015 May 20;9(5):e0003769. doi: 10.1371/journal.pntd.0003769. eCollection 2015 May.

27.

Molecular basis for mid-region amyloid-β capture by leading Alzheimer's disease immunotherapies.

Crespi GA, Hermans SJ, Parker MW, Miles LA.

Sci Rep. 2015 Apr 16;5:9649. doi: 10.1038/srep09649.

28.

Shared locations of TB cases: places of acquisition or transmission of infection?

Hermans S, Middelkoop K, Wood R.

Trop Med Int Health. 2015 Jul;20(7):965. doi: 10.1111/tmi.12493. Epub 2015 Mar 17. No abstract available.

29.

Highlights from the Third International Society for Computational Biology (ISCB) European Student Council Symposium 2014.

Francescatto M, Hermans SM, Babaei S, Vicedo E, Borrel A, Meysman P.

BMC Bioinformatics. 2015;16 Suppl 3:A1-9. Epub 2015 Feb 13.

30.

Parkinson's disease in GTP cyclohydrolase 1 mutation carriers.

Terbeek J, Hermans S, Van Laere K, Vandenberghe W.

Brain. 2015 May;138(Pt 5):e350. doi: 10.1093/brain/awu324. Epub 2014 Nov 28. No abstract available.

PMID:
25433916
31.

Crystal structure of human insulin-regulated aminopeptidase with specificity for cyclic peptides.

Hermans SJ, Ascher DB, Hancock NC, Holien JK, Michell BJ, Chai SY, Morton CJ, Parker MW.

Protein Sci. 2015 Feb;24(2):190-9. doi: 10.1002/pro.2604. Epub 2014 Dec 26.

32.

One-step double covalent functionalization of reduced graphene oxide with xanthates and peroxides.

Pennetreau F, Riant O, Hermans S.

Chemistry. 2014 Nov 10;20(46):15009-12. doi: 10.1002/chem.201405148. Epub 2014 Oct 9.

PMID:
25303099
33.

In silico identification and in vitro validation of potential cholestatic compounds through 3D ligand-based pharmacophore modeling of BSEP inhibitors.

Ritschel T, Hermans SM, Schreurs M, van den Heuvel JJ, Koenderink JB, Greupink R, Russel FG.

Chem Res Toxicol. 2014 May 19;27(5):873-81. doi: 10.1021/tx5000393. Epub 2014 Apr 23.

PMID:
24713091
34.

Tissue-specific loss of DARS2 activates stress responses independently of respiratory chain deficiency in the heart.

Dogan SA, Pujol C, Maiti P, Kukat A, Wang S, Hermans S, Senft K, Wibom R, Rugarli EI, Trifunovic A.

Cell Metab. 2014 Mar 4;19(3):458-69. doi: 10.1016/j.cmet.2014.02.004.

35.

Antiretroviral therapy and tuberculosis: does the regimen matter?

van Leth F, Wit FW, Hermans SM.

Expert Rev Anti Infect Ther. 2014 Jan;12(1):5-7. doi: 10.1586/14787210.2014.859984.

PMID:
24256498
36.

A covalently anchored homogeneous gold complex on carbon nanotubes: a reusable catalyst.

Vriamont C, Devillers M, Riant O, Hermans S.

Chem Commun (Camb). 2013 Nov 18;49(89):10504-6. doi: 10.1039/c3cc46097e.

PMID:
24084624
37.

Catalysis with Gold Complexes Immobilised on Carbon Nanotubes by π-π Stacking Interactions: Heterogeneous Catalysis versus the Boomerang Effect.

Vriamont C, Devillers M, Riant O, Hermans S.

Chemistry. 2013 Sep 2;19(36):12009-17. doi: 10.1002/chem.201300998. Epub 2013 Jul 16.

PMID:
23861243
38.

Risk of tuberculosis after antiretroviral treatment initiation: a comparison between efavirenz and nevirapine using inverse probability weighting.

Hermans SM, Manabe YC, Kiragga AN, Hoepelman AI, Lange JM, van Leth F.

Antivir Ther. 2013;18(4):615-22. doi: 10.3851/IMP2525. Epub 2013 Feb 19.

PMID:
23423604
39.

Radical addition of xanthates on carbon nanotubes as an efficient covalent functionalization method.

Vanhorenbeke B, Vriamont C, Pennetreau F, Devillers M, Riant O, Hermans S.

Chemistry. 2013 Jan 14;19(3):852-6. doi: 10.1002/chem.201203207. Epub 2012 Dec 12.

PMID:
23238882
40.

Unrecognised tuberculosis at antiretroviral therapy initiation is associated with lower CD4+ T cell recovery.

Hermans SM, van Leth F, Kiragga AN, Hoepelman AI, Lange JM, Manabe YC.

Trop Med Int Health. 2012 Dec;17(12):1527-33. doi: 10.1111/tmi.12001. Epub 2012 Nov 6.

41.

Structural and functional properties of staphylococcal superantigen-like protein 4.

Hermans SJ, Baker HM, Sequeira RP, Langley RJ, Baker EN, Fraser JD.

Infect Immun. 2012 Nov;80(11):4004-13. doi: 10.1128/IAI.00764-12. Epub 2012 Sep 4.

42.

Cost-effectiveness of early initiation of first-line combination antiretroviral therapy in Uganda.

Sempa J, Ssennono M, Kuznik A, Lamorde M, Sowinski S, Semeere A, Hermans S, Castelnuovo B, Manabe YC.

BMC Public Health. 2012 Sep 4;12:736. doi: 10.1186/1471-2458-12-736.

43.

Implementation and effect of intensified case finding on diagnosis of tuberculosis in a large urban HIV clinic in Uganda: a retrospective cohort study.

Hermans S, Nasuuna E, van Leth F, Byhoff E, Schwarz M, Hoepelman A, Lange J, Manabe YC.

BMC Public Health. 2012 Aug 20;12:674. doi: 10.1186/1471-2458-12-674.

44.

Evaluating the cost-effectiveness of combination antiretroviral therapy for the prevention of mother-to-child transmission of HIV in Uganda.

Kuznik A, Lamorde M, Hermans S, Castelnuovo B, Auerbach B, Semeere A, Sempa J, Ssennono M, Ssewankambo F, Manabe YC.

Bull World Health Organ. 2012 Aug 1;90(8):595-603. doi: 10.2471/BLT.11.095430.

45.

Rifampicin for continuation phase tuberculosis treatment in Uganda: a cost-effectiveness analysis.

Manabe YC, Hermans SM, Lamorde M, Castelnuovo B, Mullins CD, Kuznik A.

PLoS One. 2012;7(6):e39187. doi: 10.1371/journal.pone.0039187. Epub 2012 Jun 18.

46.

Comment on: predictors of immune recovery and the association with late mortality while on antiretroviral treatment in Cambodia.

Hermans SM, Sempa J, Castelnuovo B, Manabe YC, van Leth F.

Trans R Soc Trop Med Hyg. 2012 May;106(5):328-9. doi: 10.1016/j.trstmh.2012.02.004. Epub 2012 Mar 23. No abstract available.

PMID:
22445080
47.

Integration of HIV and TB services results in improved TB treatment outcomes and earlier prioritized ART initiation in a large urban HIV clinic in Uganda.

Hermans SM, Castelnuovo B, Katabira C, Mbidde P, Lange JM, Hoepelman AI, Coutinho A, Manabe YC.

J Acquir Immune Defic Syndr. 2012 Jun 1;60(2):e29-35. doi: 10.1097/QAI.0b013e318251aeb4.

48.

Earlier initiation of antiretroviral therapy, increased tuberculosis case finding and reduced mortality in a setting of improved HIV care: a retrospective cohort study.

Hermans SM, van Leth F, Manabe YC, Hoepelman AI, Lange JM, Kambugu A.

HIV Med. 2012 Jul;13(6):337-44. doi: 10.1111/j.1468-1293.2011.00980.x. Epub 2012 Feb 2.

49.

Genetics of atrial fibrillation and possible implications for ischemic stroke.

Lemmens R, Hermans S, Nuyens D, Thijs V.

Stroke Res Treat. 2011;2011:208694. doi: 10.4061/2011/208694. Epub 2011 Jul 27.

50.

Semantic abilities in children with pragmatic language impairment: the case of picture naming skills.

Ketelaars MP, Hermans SI, Cuperus J, Jansonius K, Verhoeven L.

J Speech Lang Hear Res. 2011 Feb;54(1):87-98. doi: 10.1044/1092-4388(2010/09-0116). Epub 2010 Aug 26.

PMID:
20798325

Supplemental Content

Loading ...
Support Center